Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

729 public trials 250 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor trial results

Recruiting

A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors

NCT04794972

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +7 more
Locations
  • Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Affiliated Cancer Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • ZhuJiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Shenzhen Second People's Hospital Shenzhen, Guangdong, China
View Trial Details
Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

NCT06975293

Conditions
Dedifferentiated Liposarcoma, Leiomyosarcoma, Liposarcoma, +7 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Northwell Health Cancer Institute Lake Success, New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors

NCT05701306

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Tongji Hospital, Huazhong University of Science and Technology (HUST) Wuhan, Hubei, China
  • Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

NCT06616766

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Next Oncology Virginia Fairfax, Virginia, United States
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • The Catholic Univ. of Korea St. Vincent's Hospital Suwon, Gyeonggi-do, South Korea
  • Chungbuk National University Hospital Cheongju-si, North Chungcheong, South Korea
View Trial Details

Related conditions